These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
760 related articles for article (PubMed ID: 34402862)
1. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma. Ma W; Zhong M; Liu X Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34402862 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma. Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma. Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670 [TBL] [Abstract][Full Text] [Related]
4. A Risk Signature with Autophagy-Related Long Noncoding RNAs for Predicting the Prognosis of Clear Cell Renal Cell Carcinoma: Based on the TCGA Database and Bioinformatics. Xuan Y; Chen W; Liu K; Gao Y; Zuo S; Wang B; Ma X; Zhang X Dis Markers; 2021; 2021():8849977. PubMed ID: 34040677 [TBL] [Abstract][Full Text] [Related]
5. A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma. Zhou J; Liu G; Wu X; Zhou Z; Li J; Ji Z Dis Markers; 2021; 2021():8863799. PubMed ID: 33510822 [TBL] [Abstract][Full Text] [Related]
6. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data. Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717 [TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Nine-Redox-Related Long Noncoding RNA Signature in Renal Clear Cell Carcinoma. Qi-Dong X; Yang X; Lu JL; Liu CQ; Sun JX; Li C; Wang SG Oxid Med Cell Longev; 2020; 2020():6634247. PubMed ID: 33425212 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma. Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930 [TBL] [Abstract][Full Text] [Related]
9. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma. Zhang J; Zhang X; Piao C; Bi J; Zhang Z; Li Z; Kong C Biomed Pharmacother; 2019 Oct; 118():109079. PubMed ID: 31351427 [TBL] [Abstract][Full Text] [Related]
10. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688 [TBL] [Abstract][Full Text] [Related]
11. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma. Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371 [TBL] [Abstract][Full Text] [Related]
12. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Yu J; Mao W; Xu B; Chen M Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306 [TBL] [Abstract][Full Text] [Related]
13. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma. Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816 [TBL] [Abstract][Full Text] [Related]
14. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma. Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284 [TBL] [Abstract][Full Text] [Related]
15. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma. Zhou L; Fang H; Guo F; Yin M; Long H; Weng G J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868 [TBL] [Abstract][Full Text] [Related]
16. A novel necroptosis-related lncRNAs signature for survival prediction in clear cell renal cell carcinoma. Zhao L; Luo H; Dong X; Zeng Z; Zhang J; Yi Y; Lin C Medicine (Baltimore); 2022 Sep; 101(39):e30621. PubMed ID: 36181033 [TBL] [Abstract][Full Text] [Related]
17. Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma. Wang N; Hu Y; Wang S; Xu Q; Jiao X; Wang Y; Yan L; Cao H; Shao F Sci Rep; 2024 Jan; 14(1):624. PubMed ID: 38182642 [TBL] [Abstract][Full Text] [Related]
18. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma. Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605 [TBL] [Abstract][Full Text] [Related]
19. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma. Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763 [TBL] [Abstract][Full Text] [Related]
20. Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma. Liu JW; Supandi F; Dhillon SK Folia Biol (Praha); 2022; 68(1):1-15. PubMed ID: 36201853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]